Nectar Lifesciences Limited — Results, 31-01-2025: Integrated Filing- Financial

Nectar Lifesciences Ltd. has announced a board meeting to discuss the financial results for the quarter and nine months ended December 31, 2024. For Q3, the company reported total income of ₹45,555.51 crores, with a profit before tax of ₹1,254.78 crores. Profit after tax stood at ₹784.04 crores, reflecting a healthy opportunity for growth despite a slight decline in revenues compared to the previous year. This update suggests strong operational performance, potentially boosting investor sentiment as the company navigates its pharmaceutical segment strategically.